Aptamer Microarrays—Current Status and Future Prospects

@inproceedings{Witt2015AptamerMS,
  title={Aptamer Microarrays—Current Status and Future Prospects},
  author={Martin Witt and Johanna-Gabriela Walter and Frank Stahl},
  booktitle={Microarrays},
  year={2015}
}
Microarray technologies are state of the art in biological research, which requires fast genome, proteome and transcriptome analysis technologies. Often antibodies are applied in protein microarrays as proteomic tools. Since the generation of antibodies against toxic targets or small molecules including organic compounds remains challenging the use of antibodies may be limited in this context. In contrast to this, aptamer microarrays provide alternative techniques to circumvent these… CONTINUE READING
4
Twitter Mentions

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Towards targeted cancer therapy: Aptamer or oncolytic virus?

  • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 76 REFERENCES